Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford

      Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford

      Medical Dialogues Bureau22 Aug 2019 9:30 AM IST
      The investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
      AstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKD

      AstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKD

      Medical Dialogues Bureau22 Aug 2019 9:20 AM IST
      This marketing authorization follows the approval of Roxadustat in China in December 2018 for anaemia in CKD patients who are on dialysis. AstraZeneca...
      GSK: US pharma president Jack Bailey to step down in December

      GSK: US pharma president Jack Bailey to step down in December

      Medical Dialogues Bureau22 Aug 2019 9:15 AM IST
      Commenting on his time at GSK, Jack Bailey said, "After more than a decade at GSK and nearly three decades in the life sciences industry, I look...
      Simple, uncluttered and transparent, Fortis CEO plans makeover: Report

      Simple, uncluttered and transparent, Fortis CEO plans makeover: Report

      Medical Dialogues Bureau21 Aug 2019 11:40 AM IST
      These are just the first steps by Raghuvanshi to nurse Fortis back to health after a tumultuous year where its former owners, Malvinder Singh and...
      Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

      Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

      Medical Dialogues Bureau21 Aug 2019 10:00 AM IST
      The audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
      Alembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara

      Alembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara

      Medical Dialogues Bureau21 Aug 2019 9:45 AM IST
      New Delhi: Drug firm, Alembic Pharmaceutical's bioequivalence facilities located at Vadodara have been successfully inspected by the US Food &...
      Dr Reddys launches generic version of Sabril powder in US to treat epilepsy

      Dr Reddy's launches generic version of Sabril powder in US to treat epilepsy

      Medical Dialogues Bureau21 Aug 2019 9:30 AM IST
      Dr Reddy's anti-epileptic Vigabatrin is a generic version of Lundbeck's Sabril powder for oral solution.New Delhi: Drug firm Dr Reddy's Laboratories...
      Teva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packs

      Teva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packs

      Medical Dialogues Bureau21 Aug 2019 9:15 AM IST
      Teva Pharma, the world’s largest generic drugmaker, is already selling the product for adults, after getting U.S. approval for its copy of EpiPen last...
      Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion

      Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion

      Medical Dialogues Bureau21 Aug 2019 9:00 AM IST
      Bayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending...
      Dr Reddys unveils VERSAVO, biosimilar to Roche Avastin to treat types of cancers in India

      Dr Reddy's unveils VERSAVO, biosimilar to Roche Avastin to treat types of cancers in India

      Medical Dialogues Bureau20 Aug 2019 10:00 AM IST
      According to Ipsos India Tandem Oncology Monitor 2018, Avastin and its biosimilars had India sales of around Rs 223 crore (moving annual total) MAT...
      Glenmark wins regulatory nod to market diabetes drug under brand names Remo-M, Remozen-M in India

      Glenmark wins regulatory nod to market diabetes drug under brand names Remo-M, Remozen-M in India

      Medical Dialogues Bureau20 Aug 2019 9:45 AM IST
      Glenmark Pharma will commercialise the combination of Remogliflozin etabonate and Metformin hydrochloride film-coated tablets in India under the brand...
      Sarepta Therapeutic fails to win USFDA approval for second Duchenne treatment Golodirsen

      Sarepta Therapeutic fails to win USFDA approval for second Duchenne treatment Golodirsen

      Medical Dialogues Bureau20 Aug 2019 9:15 AM IST
      Analysts had expected annual sales of nearly $400 million in five years for golodirsen, the second treatment from Sarepta for DMD, a rare...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok